Showing results 1 to 7 of 7
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2013 | 75 | |||
2011 | 50 | |||
A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer Journal:Clinical Colorectal Cancer | 2011 | 63 | ||
2011 | 68 | |||
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors Journal:Cancer Medicine | 2013 | 84 | ||
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors Journal:Invest New Drugs | 2014 | 59 | ||
Use of plasma angiome to predict PFS in patients with metastatic colorectal cancer (mCRC) treated with capecitabine, oxaliplatin, and bevacizumab (XELOX-A) Proceeding/Conference:Journal of Clinical Oncology | 2010 |